By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Covance today said that it will collaborate with the Broad Institute on microRNA expression research on an unidentified research model.

Princeton, NJ-based Covance said that the collaboration will utilize its next-generation sequencing capabilities to profile microRNA expression in various tissue samples from the model, which the firm said has proven valuable for understanding various human diseases including respiratory, oncology, and cardiovascular diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.